Activity against breast cancer stem-like cells by reducing the expression of CD44, Oct4, Notch2, β-catenin and Sox2 proteins, associated with enhanced sensitivity of cells to the ionizing radiation and standard chemotherapeutic drugs (taxol, cisplatin and etoposide). The gene discussed is NOTCH2; the disease is breast carcinoma.